scientific outreach

Sales & Marketing

Field medical education before launch is linked to greater launch success, improving treatment adoption by up to 50%.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.